FDA Import Refusal M21-0749782-0/1/1 — Globela Pharma Pvt Ltd.
The FDA refused shipment M21-0749782-0/1/1 from Globela Pharma Pvt Ltd. (India) on Mar 24, 2014. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 24, 2014
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCS55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 118,3280